MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202617070165 A) filed by Tyk Medicines, Inc. on June 04, 2026, for Compound For Egfr Protein Degradation And Use Thereof.
Inventors include Liang, Apeng; Han, Shunxun; Chen, Shaoqing; Wu, Yusheng; Li, Jun Number; and Dong, Shengli.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention relates to a compound for EGFR protein degradation and a use thereof. Specifically, the compound of the present invention has a structure represented by formula III, wherein the definition of each group and substituent is as described in the description. Also disclosed in the invention are a preparation method for the compound and a use of same in the prevention and/or treatment of EGFR-related diseases.
Disclaimer: Curated by HT Syndication.
